Latest News
Adimab partner GSK receives additional marketing approvals for depemokimab
16 April 2026 - Adimab LLC, a provider of therapeutic antibody discovery and engineering technologies, said on Wednesday that it congratulates biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) for recently receiving approvals from the European C...
Seragon reports SRN-901 longevity drug data
16 April 2026 - Research-based biopharmaceutical company Seragon Biosciences Inc announced on Wednesday the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development and Therapy, demonstrating that i...
Gallant reports positive pilot data for feline OA stem cell therapy and FDA eligibility for expanded conditional approval pathway
16 April 2026 - Animal health biotechnology company Gallant on Wednesday reported positive results from a pilot clinical study evaluating intravenous (IV) uterine-derived mesenchymal stromal cell (UMSC) therapy in cats with naturally occurring osteoa...
Lunai Bioworks and Geneial enter into LOI to build rare disease patient cohorts for drug development partnerships
15 April 2026 - AI-driven drug discovery company Lunai Bioworks Inc (NASDAQ: LNAI) reported on Wednesday that it has entered into a non-binding Letter of Intent through its BioSymetrics subsidiary with precision medicine data infrastructure company G...
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
15 April 2026 - Medical device company QT Imaging Holdings Inc (Nasdaq:QTI) announced on Wednesday the launch of the QT Imaging-Olea Viewer, developed in collaboration with Olea Medical, a leader in advanced imaging software solutions.The viewer prov...